A retrospective study to evaluate frequency and severity of peri-procedural complications and post-procedural adverse events in patients with right hemihepatectomy undergoing chemosaturation percutaneous hepatic perfusion
Latest Information Update: 11 Jun 2021
At a glance
- Drugs Melphalan (Primary)
- Indications Advanced breast cancer; Carcinoma; Cholangiocarcinoma; Colorectal cancer; Liver cancer; Liver metastases; Neuroendocrine carcinoma; Pancreatic cancer; Uveal melanoma
- Focus Adverse reactions; Therapeutic Use
- 11 Jun 2021 New trial record